Clinical trial
An Observational Cohort Study to Evaluate the Expression Profiles of Oocyte-potency-related Genes in Ovarian Cumulus Cells From Patients Treated by Intracytoplasmic Sperm Injection (ICSI) That Are Treated With Recombinant Gonadotropins
NCT04710264 is registered in ClinicalTrials.gov with Fertiga, Belgium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Cohort Study to Evaluate the Expression Profiles of Oocyte-potency-related Genes in Ovarian Cumulus Cells From Patients Treated by Intracytoplasmic Sperm Injection (ICSI) That Are Treated With Recombinant Gonadotropins
- Lead sponsor
- Fertiga, Belgium
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 15, 2021
- Completion date
- September 1, 2025
- Enrollment
- 137 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.